English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Inhibition of proteasome rescues a pathogenic variant of respiratory chain assembly factor COA7

Mohanraj, K., Wasilewski, M., Benincá, C., Cysewski, D., Poznanski, J., Sakowska, P., et al. (2019). Inhibition of proteasome rescues a pathogenic variant of respiratory chain assembly factor COA7. EMBO Molecular Medicine, 11(5): e9561. doi:10.15252/emmm.201809561.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0003-60D8-D Version Permalink: http://hdl.handle.net/21.11116/0000-0003-92F5-3
Genre: Journal Article

Files

show Files
hide Files
:
3047449.pdf (Publisher version), 3MB
Name:
3047449.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show

Creators

show
hide
 Creators:
Mohanraj, K., Author
Wasilewski, M., Author
Benincá, C., Author
Cysewski, D., Author
Poznanski, J., Author
Sakowska, P., Author
Bugajska, Z., Author
Deckers, M., Author
Dennerlein, S., Author
Fernandez‐Vizarra, E., Author
Rehling, P.1, Author              
Dadlez, M., Author
Zeviani, M., Author
Chacinska, A., Author
Affiliations:
1Max Planck Fellow Peter Rehling, ou_1298545              

Content

show
hide
Free keywords: -
 Abstract: Nuclear and mitochondrial genome mutations lead to various mitochondrial diseases, many of which affect the mitochondrial respiratory chain. The proteome of the intermembrane space (IMS) of mitochondria consists of several important assembly factors that participate in the biogenesis of mitochondrial respiratory chain complexes. The present study comprehensively analyzed a recently identified IMS protein cytochrome c oxidase assembly factor 7 (COA7), or RESpiratory chain Assembly 1 (RESA1) factor that is associated with a rare form of mitochondrial leukoencephalopathy and complex IV deficiency. We found that COA7 requires the mitochondrial IMS import and assembly (MIA) pathway for efficient accumulation in the IMS. We also found that pathogenic mutant versions of COA7 are imported slower than the wild‐type protein, and mislocalized proteins are degraded in the cytosol by the proteasome. Interestingly, proteasome inhibition rescued both the mitochondrial localization of COA7 and complex IV activity in patient‐derived fibroblasts. We propose proteasome inhibition as a novel therapeutic approach for a broad range of mitochondrial pathologies associated with the decreased levels of mitochondrial proteins.

Details

show
hide
Language(s): eng - English
 Dates: 2019-03-182019-05
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: Peer
 Identifiers: DOI: 10.15252/emmm.201809561
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: EMBO Molecular Medicine
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: 21 Volume / Issue: 11 (5) Sequence Number: e9561 Start / End Page: - Identifier: -